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The most remarkable histologic feature of the inflammatory reaction 
produced in response to a viral infection is the localized accumulation of 
mononuclear cells, usually identified as lymphocytes and macrophages. This 
is true of the perivascular cuffing described for viral pneumonias or 
encephalitides as well as the more diffuse but still localized dermal 
reaction to vaccinia. Yet surprisingly little is known about what these cells 
are doing, especially when contrasted to the well defined functions of 
neutrophiles in the inflammatory response to bacterial infection. Virus- 
induced lesions are histologically similar to those of delayed hyper¬ 
sensitivity reactions; however, until recently, little had been added to 
this otherwise superficial relationship. 
Recent developments in immunology, virology, and cell culture 
techniques have made possible the study of reactions and interactions of 
well defined cell populations in response to viral stimuli. With the 
identification, by Isaacs and Lindenmann in 1958, of a protein substance 
produced in response to viral infections and capable of inhibiting virus 
multiplication and virus-induced cell damage (32), a great surge of interest 
was aroused in the biochemistry of cellular responses to viruses. Of 
special interest was the observation that this protein, now called interferon. 
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acted on the susceptible cell rather than on the virus itself, as does 
antibody. 
Concomitantly, immunologists were becoming increasingly aware of the 
versatility of the lymphocyte which, they found, could respond to various 
stimuli by the production of proteins capable of causing striking changes in 
other cells (3). The old distinction between cellular and humoral immunity 
and the histologic changes accompanying each could now be viewed as 
resulting from the qualitatively different products produced by cells in 
response to exogenous stimuli. The cellular products in delayed hyper¬ 
sensitivity have their primary action on other cells, whereas the cellular 
products in humoral immunity have their primary action on the stimulus itself 
While the importance of interferon in recovery from viral infections 
has justifiably gained wide and rapid acceptance, the role of the more 
conventional immune responses has been largely neglected or dismissed (2, 29) 
Recent reviews of the subject have considered and contrasted the relative 
roles of interferon, antibody, and delayed hypersensitivity as if they were 
entirely separable entities. Reflecting the experimental questions asked by 
individual investigators, these reviews have emphasized the differences in 
the three responses and, from these differences, have extrapolated to 
differences in significance. 
This thesis presents experimental evidence linking interferon 
production to delayed hypersensitivity and reinterprets some of the relevant 
preexisting data. It emphasizes the immunologic rather than the non- 
immunologic aspects of interferon production, and aims toward a more unified 





Available evidence indicates that interferon is a protein with the 
ability to inhibit viral multiplication intracellularly (37). It has a 
molecular weight of 25,000-100,000, is stable over the pH range 1-10, and 
slowly loses titer at 37°C. but not at -20°C. Its anti-viral effect is 
nonspecific; to varying degrees it will inhibit multiplication of virtually 
all animal viruses. Its effectiveness is species specific; its anti-viral 
effect is best or solely demonstrated in cells or animals of the species 
from which it was derived. 
_2. Methods of Induct ion 
Interferon can be isolated from the serum or organs of many different 
animals infected with RNA or DNA viruses. The in vitro production of 
interferon has been observed in cell lines from species as diverse as fish 
and man (7). Differences in the ability of different cells to produce 
interferon have remained unexplained. Likewise, it is not known why some 
viruses are better inducers of interferon than others. In most mouse cells, 
arboviruses have been good inducers of interferon. 
The mechanism of interferon induction and the characteristics of the 
interferon produced seem to vary according to the nature of the inducing 
agent. One class of inducers is the viruses; the currently accepted 
hypothesis is that they derepress a host cell gene which codes for 
interferon (15). Endotoxin is the prototype of another class of inducers 
which are thought to cause the release of "preformed1' interferon rather than 
initiate its de novo synthesis (30, 31). 
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It has been shown that peak titers of endotoxin-induced interferon 
are reached much more rapidly than peak titers of virus induced 
interferon (31). Also, in vivo concentrations of actinomycin D sufficient 
to inhibit virus-induced interferon production do not inhibit endotoxin- 
induced interferon production (31). 
The validity of using these observations as the basis for making a 
mechanistic distinction between classes of inducers may be questioned. 
Many attempts to induce interferon with endotoxin In vitro have failed, and 
the endotoxin experiments which use inhibitors of ENA and protein synthesis 
have been done rn vivo. Recently, Smith and Wagner reported _in vitro 
endotoxin-induced interferon production in purified rabbit macrophages (46). 
They found that induction by this method was inhibited by actinomycin D. 
Sauter and Gifford measured in vivo levels of interferon and a lysosomal 
enzyme following intravenous administration of endotoxin and found that both 
reached maximum titers at two hours (43). They concluded that interferon 
may be released from lysosomes. Another interpretation is that interferon 
increases cell membrane permeability to proteins, thereby allowing interferon 
to escape more rapidly than it does with virus-inducers. 
Endotoxin-induced interferon has also been observed to have different 
physical characteristics from virus-induced interferon. It is reported to 
have a greater molecular weight (30) and to be less heat and acid stable 
than virus-induced interferon from the same animals (31). Until interferon 
can be purified, it is difficult to know the significance of these 
observations. 
Other aspects of endotoxin-induced interferon must be considered by 
any investigator working with culture media that may contain pyrogen. Two 
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investigators have demonstrated _in vitro interferon production induced by 
endotoxin; in one case, anti-endotoxin antibody enhanced the response (46, 6). 
Tolerance, or the inability of animals or cells to make interferon for a 
variable period after injection of virus or endotoxin, may prove to have 
in vitro significance. For instance, some cells are unable to produce 
interferon in response to viruses if they are cultured for several hours 
before challenge (5, 53). Conceivably, this phenomenon could be due to 
tolerance induced by endotoxin present in the media. 
3. Mechanism of Action 
The mechanism of action of interferon is unknown. Interferon does 
not directly inactivate virus particles or infectious nucleic acid, nor does 
it affect virus adsorption, penetration, or uncoating. It does not appear 
to inhibit host cell protein synthesis or the activity of specific viral 
enzymes (45). 
Studies with antimetabolites have shown that host cell DNA-dependent 
RNA synthesis and protein synthesis are necessary for interferon action. 
The hypothesis that interferon acts as a derepressor for the synthesis of 
another cellular protein, which may act in conjunction with interferon or 
may be the anti-viral molecule itself, is consistent with available 
experimental data. Recent evidence, reviewed by Vilcek, has focused 
attention on the ribosome as the site of anti-viral action (50). 
As with interferon induction, variability in the responsiveness of 
different cells or viruses to the action of interferon is a frequently 
observed but poorly understood phenomenon. Vesicular stomatitis virus and 
mouse L cells have been widely used as an assay system for mouse interferon. 
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Even with this system, however, different sensitivities have been reported 
for different clones of cells and mutants of the virus (36). 
B. INTERFERON PRODUCTION BY LYMPHOCYTES AND MACROPHAGES 
Lymphocytes and macrophages have been shown to produce interferon 
in vitro and indirect evidence implies that they are also important in vivo 
sources of interferon (13, 28, 35, 46, 53). 
The most convincing Tn vivo evidence has been presented by DeMaeyer 
et al, who irradiated C^H/He mice with 1000 rads, restored their bone marrow 
with Wistar rat marrow cells, and three weeks later challenged them with 
Newcastle Disease Virus (13). Whereas unrestored irradiated animals 
produced no detectable circulating interferon in response to the challenge, 
animals restored with rat cells produced interferon proportional to the rate 
of marrow repopulation and having the specificity of rat interferon. 
In vitro studies designed to elucidate which of the bone marrow- 
derived cells produce interferon show that both macrophages and lymphocytes 
produce interferon. However, the details of the experiments caution against 
generalization. Rabbit macrophages produce interferon in response to viruses 
and purified endotoxin (46), whereas mouse macrophages respond to viruses but 
not endotoxin (48). It is not known whether this represents a relative or 
absolute species insensitivity to endotoxin. Studies with lymphocytes 
indicate that these cells make interferon in response to viruses, phyto¬ 
hemagglutinin, pokeweek mitogen, and streptolysin 0 (20, 28, 53). These 
experiments with lymphocytes all used human blood cells and, although 
attempts were made in two cases to purify the cells, the reports lacked a 
critical evaluation of the purification procedures. Because of this, some 
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doubt must remain as to which cell type in those preparations produced the 
interferon, but the burden of proof now seems to fall on those who would 
maintain that lymphocytes do not produce interferon. 
The methods of collection and culture of cells can influence 
interferon production. Wheelock observed that if his purified lymphocytes 
were cultured for more than two hours before challenge with NDV they lost 
their ability to produce interferon (53). This was not, however, observed 
if PHA was the inducer. Smith and Wagner found that all of their culture 
media contained pyrogen and that cultures of uninfected rabbit macrophages 
produced low titers of interferon (46). Also, macrophages from peritoneal 
cavities stimulated with glass beads 72 hours before collection produced 
far more baseline interferon than macrophages from unstimulated peritoneal 
exudate. The authors suggest that nonspecific mobilization of macrophages 
can partially activate them to produce interferon. 
C. DELAYED HYPERSENSITIVITY 
1_. In Vivo 
Delayed hypersensitivity is the capacity of animals to manifest 
characteristic pathological changes in response to antigenic stimuli. The 
histologic features of this reaction to antigen are perivascular and tissue 
accumulations of lymphocytes and macrophages followed by widely varying 
degrees of tissue necrosis, fibrinoid necrosis of blood vessels, and 
accumulation of polymorphonuclear leucocytes (51). The chief operational 
characteristics of delayed hypersensitivity are its immunologic specificity 
and its requirement for specific lymphoid cells rather than humoral antibody. 
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On the basis of similar histologic features and the above mentioned operational 
requirements, such seemingly diverse entities as tuberculin skin sensitivity, 
contact allergy, and homograft rejection can all be termed delayed hyper¬ 
sensitivity reactions. 
_2. _In Vitro 
Studies of lymphocytes in vitro have greatly aided the understanding 
of the mechanism whereby these cells effect the pathological changes 
observed. In the presence of antigen, lymphocytes from animals specifically 
sensitized to that antigen have been shown to release several biologically 
active molecules (all tentatively identified as proteins). These include a 
factor which inhibits macrophage migration (4, 12), a factor which is 
cytotoxic for a variety of cells (42, 25), a factor which is chemotactic for 
macrophages (52), a factor which induces blast transformation in 
lymphocytes (17), and a factor which transfers delayed skin reactivity (34). 
Normal lymphocytes will respond to mitogens by producing some of the above 
factors and, in addition, interferon (3). Why interferon is found in consort 
with these other proteins is unknown. Furthermore, the possibility exists 
that a single protein may possess the properties of several of the above 
mentioned factors. 
_3. Jn Mice 
Most demonstrations of delayed hypersensitivity in mice have been 
indirect (increased susceptibility to endotoxin shock) (26) or 
unconvincing (11, 1), except when replicating antigens such as live 
Mycobacterium hominis have been used (14). Kantor recently reviewed and 
clarified the problem by testing 25 mouse species for delayed hypersensitivity 
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to heat killed Mycobacterium (33). He found marked species variability to 
footpad injections of PPD and showed that BALB/c and C^H mice were the best 
reactors. Gross measurement of the feet correlated well with the severity 
of the histologic lesions. The delayed hypersensitivity could be transferred 
to normal mice with peritoneal exudate cells but not with spleen or lymph 
node cells. 
A* Virus Infections 
The histologic changes seen in virus infections are frequently 
indistinguishable from those seen in delayed hypersensitivity reactions. 
Whether these changes represent an immunologic reaction to viral antigens 
or are the nonspecific consequence of direct cell damage caused by the 
virus is unknown. There is some experimental evidence, as well as 
interpretations of "experiments of nature," that suggest a role for delayed 
hypersensitivity in virus infections. 
People with agammaglobulinemia in whom there is no deficiency in 
cellular or delayed immunity, as evidenced by their ability to react in 
the usual way to skin grafts or skin tests for delayed hypersensitivity, 
have no difficulty recovering from most viral infections. In contrast, 
people with congenital deficiencies in their ability to develop delayed 
reactions often die in childhood from viral illnesses (44). 
Experimentally, peritoneal cells, but not serum, from animals 
infected with fibroma virus confer partial resistance to fibroma in other 
animals (22). The macrophage migration inhibition experiment, described by 
George and Vaughn (21) and interpreted as an rn vitro manifestation of delayed 
hypersensitivity, also works using cells from mice immunized with mumps and 
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influenza viruses (16). Newborn rabbits, rendered tolerant to vaccinia by 
the injection of heat killed virus, developed progressively lethal vaccinia 
when challenged several days later with live virus; none of the control 
animals died (18). Interestingly, only a minimal local lesion was found in 
the tolerant animals and the investigators cautiously suggested that the 
skin lesion of primary vaccinia, as well as the prevention of generalized 
vaccinia in newborn rabbits, was due to delayed-type hypersensitivity. 
Using a different approach, others have shown that guinea pigs made 
immunologically unresponsive by x-irradiation and treatment with methotrexate 
recovered from vaccinia infections as rapidly as controls, but were 
subsequently unable to give delayed skin reactions to heat-killed 
vaccinia (19). Furthermore, the amount of interferon found in homogenates 
of primary skin lesions was equal in immunologically paralyzed and in 
control animals. These results were interpreted as showing that interferon 
was responsible for the recovery from viral infections and that delayed 
hypersensitivity and antibody played little, if any, role. This work would 
have been far more convincing if it had demonstrated that the "immunologically 
unresponsive" animals also failed to react to more typical delayed hyper¬ 
sensitivity-evoking stimuli. 
_5. Acquired Cellular Resistance 
Animals infected with intracellularly replicating bacteria develop 
both an immunologically specific and nonspecific ability to resist 
reinfection (38). Macrophages from such animals have an increased capacity 
to destroy ingested microorganisms, even in the absence of conventional 
antibody. Macrophages are thus thought to be the effector cell for the 
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in vivo phenomenon called acquired cellular resistance. Such resistance is 
believed to be the result of nonspecific activation of macrophages secondary 
to specific lymphocyte-antigen interaction. It has been observed with 
bacteria, fungi, and protozoa and correlates well with increased macrophage 
production of lysosomal enzymes (38). Acquired cellular resistance has been 
used to explain the fibroma virus experiment mentioned above as well as 
other demonstrations of decreased virus replication after reinfection (47). 
It adds little, however, to the understanding of the mechanisms involved in 
these virus experiments unless it. can be distinguished from or correlated 
with known immune reactions and/or interferon. 
Animals displaying acquired cellular resistance also commonly have 
delayed hypersensitivity to the infecting organism. The relationship 
between these two altered states of reactivity is unknown, but two 
possibilities have been suggested (39): [1] sensitized lymphocytes react 
with antigen and produce a pharmacologically active substance which in turn 
causes changes in macrophages; [2] sensitized lymphocytes react with antigen 
and produce a cytophilic antibody which, when combined with antigen, causes 
changes in macrophages. 
D. EFFECT OF IMMUNITY ON INTERFERON PRODUCTION 
Animals making interferon in response to a virus develop immunity 
(cellular or humoral or both) to that virus. How immunity affects or relates 
to interferon production was the subject of experiments reported by 
Glasgow (23). Peritoneal cells from CD-I mice immunized against Chikungunya 
virus (CV) were challenged in vitro with live CV. Culture fluids assayed 
for interferon showed that cells from immune animals produced two to ten 
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times more interferon than cells from control animals. This increase was 
specific for CV; other viruses did not produce the effect in CV immune cells. 
It was also shown that the rate of adsorption of CV was equal in control and 
CV immune cells; that virus neutralized with antibody resulted in a poor but 
equal response in both normal and immune cells; and that normal cells exposed 
to anti-CV antibody and then washed produced nearly as much interferon in 
response to CV as cells not exposed to antibody. Glasgow’s conclusion was 
that the enhanced interferon production by immune cells provided a mechanism 
whereby cellular immunity could influence viral infections. 
* * * 
The work to be described in this thesis was undertaken to confirm 
and extend Glasgow's observations. Of special interest were the relative 
roles of macrophages and lymphocytes in the enhanced response observed with 
crude peritoneal exudate cells. Experiments were designed to test two 
theoretical interpretations of Glasgow’s results: 
1. If increased interferon production is analogous to acquired 
cellular resistance, macrophages should be the important effector cell. 
It might also be expected that lymphocytes are important in making the 
reaction immunologically specific. 
2. If the increased interferon production is a manifestation of a 
delayed hypersensitivity reaction, then other in vitro examples of delayed 
hypersensitivity reactions should yield the same result. 
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MATERIALS AND METHODS 
A. MICE 
Random-bred six week old male Swiss ICR mice, from a colony maintained 
by the Division of Animal Care at Yale, were used for all experiments with 
viruses and for the initial experiments with tuberculin-sensitized animals. 
Inbred six week old male BALB/c mice, obtained from Jackson Farms, Bar 
Harbor, Maine, were used for the definitive studies with tuberculin- 
sensitized animals. 
B. CONTINUOUS LINE CELL CULTURE 
L cells (clone 929), an established line of mouse fibroblasts, were 
a gift from Dr. Hilton B. Levy. Cells were grown in growth medium (see 
Appendix) in 250 ml. screw-top plastic flasks (Falcon Plastics) which were 
gassed with a mixture of 5% ^2^95% air. Cells were transferred by 
decanting the growth medium, washing the cell sheet with Saline A, and 
incubating for five minutes at 37°C. with 0.5 ml. of a trypsin (0.125%): 
versene (1:10,000) mixture. Cells were split and transferred 1-2 times per 
week, depending on the need for them. Attempts to isolate possible mycoplasma 
contaminants from these cells and culture media were negative. 
C. VIRUSES 
All viruses were obtained from the W.H.0. Arbovirus Reference 
Laboratory of the Yale Arbovirus Research Unit. ■ Two pools of Chikungunya 
virus (CV, 175th baby mouse brain passage) were prepared by intracerebral 
inoculation of three day old mice with 0.02 ml. of the 10% virus 
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preparation reconstituted with PBS. Two days after infection, the brains of 
dying mice were aseptically removed with scissors and forceps, made into a 
10% suspension in PBS by repeated passage through a 20 guage needle, and 
centrifuged for 20 minutes at 10,000 r.p.m. (12,350 g) in a Sorvall RC-2 
refrigerated centrifuge. Aliquots of the supernatant, were placed in 
ampoules, shell-frozen in dry ice-ethanol, and vacuum desiccated for six 
hours at lm of Hg. The ampoules were then filled with , sealed, and 
stored at -70°C. in a Revco freezer. These preparations maintained their 
titers for at least three months. (E.G., Pool 1 had an intracerebral titer 
of LD^q=10 ^‘^-lO ^’0/0.02 ml. in suckling mice.) 
Vesicular Stomatitis Virus (VSV), Indiana strain, from the eighth 
baby mouse brain passage, was prepared in pools in a manner similar to that 
for CV except that it was suspended in PBS + 0.75% bovine albumin. 
West Nile virus (WN) was from the eleventh baby mouse brain passage. 
D. METHODS OF SENSITIZATION 
1. Virus 
Groups of 20-30 six week old Swiss ICR mice were immunized by three 
weekly intraperitoneal injections of 0.1 ml. of live Chickungunya virus, 
rehydrated from the lyophilized form to a 10 ^ dilution with sterile PBS. 
An equal number of animals injected intraperitoneally with 0.1 ml. of a 10% 
suspension of baby mouse brain (BMB) served as controls. Three to twelve 
weeks after the last injection, the animals were sacrificed for in vitro 
testing of their peritoneal cells. 
One group of animals was immunized as above except that the virus 
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suspension was emulsified with an equal volume of Freund's incomplete 
adjuvant (85% Bayol F, 15% Arlacel A). 
Another group of animals was immunized by 0.033 ml. of live CV (10 
given in each of three footpads. This group received two such injections 
and was sacrificed three weeks after the last injection. 
An average of one animal per group died before sacrifice. 
2_. Mycobacterium Tuberculosis (MT) 
Mycobacterium tuberculosis hominis, strains C, DT, and PN, heat 
killed, washed, and dried on 9/24/58, were obtained from Dr. Byron Waksman. 
Both Swiss ICR and BALB/c mice were immunized with MT. 
Groups of 40-50 six week old mice were anesthetized with ether and 
injected in each of three footpads with 0.033 ml. of MT suspended in 
Bayol F (1 mg./ml.). Each animal thus received 100yg. of MT. Control 
animals were either sacrificed for iai vitro testing of their peritoneal cells 
or were footpad tested with PPD. 
E. FOOTPAD TESTING 
Animals were anesthetized with ether and tested in the footpad which 
had not been used for immunization ten days previously. The test dose was 
25 yg. PPD (Parke, Davis & Co.) in 0.05 ml. PPD diluent. Twenty-four hours 
later, the animals were killed and the largest dorsal-ventral diameter of 
the footpad was measured with a vernier caliper. 
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F. IN VITRO CULTURE OF MOUSE PERITONEAL CELLS 
jl. Crude Peritoneal Exudate 
Mice were rapidly killed with ether. The abdominal skin was washed 
with 70% ethanol and reflected. All further manipulations were done 
aseptically. With a Pasteur pipette, 1 1/2 - 2 ml. of cold (4°C.) peritoneal 
exudate harvesting medium (see Appendix) was introduced into the peritoneal 
cavity. Ten minutes later the fluid was withdrawn, using a Pasteur pipette, 
and centrifuged for five minutes at 900 r.p.m. (300 g) in a refrigerated 
International Centrifuge. The resulting supernatant was carefully and 
thoroughly removed by aspiration, and the cells were resuspended in 
peritoneal exudate maintenance medium (see Appendix) by gentle pipetting. 
2 
The cells were counted and distributed to 75 ml. (25 mm ) plastic 
screw-top flasks (Falcon Plastics) so that each flask contained 5x10^ cells 
in a final volume of 4 ml. maintenance medium. Flasks were gassed with 5% 
C02:95% air, tightly capped, and incubated at 37°C. Each mouse yielded 
2-4x10^ cells. 
2. Purified Macrophage Preparation 
Crude peritoneal exudate was prepared as above. 10^ cells were 
placed in each flask and, after incubation for one hour at 37°C., non¬ 
adherent cells were removed by gentle agitation and aspiration. Adherent 
cells were washed two times with maintenance medium. Approximately 5-6x10 
cells remained adherent after washing and these were predominantly 
macrophages (see below). 
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_3. Purified Lymphocyte Preparation 
The non-adherent cells from the first aspirate of the crude peritoneal 
exudate preparation which had been allowed to incubate for one hour at 37°C. 
were predominantly lymphocytes. They could be further purified by another 
one hour incubation at 37°C. Approximately 3-4x10^ non-adherent cells could 
be recovered after the second adsorption, and these were predominantly 
lymphocytes (see below). 
G. CELL STAINING AND ENUMERATION 
1_. Counting 
Cells were diluted in Turk’s solution (3% acetic acid, 1% crystal 
violet) and counted in a Beckman hemocytometer. 
2_. Gi ems a 
Using a Giemsa stain of mouse peritoneal cells prepared in a manner 
similar to that described above, Cohn reported that 50-60% of the crude 
exudate cells were macrophages while the rest were lymphocytes (9). In 
trying to duplicate that observation using a standard Giemsa stain, it was 
found that approximately 50% of the cells were easily identified as 
macrophages and 30% as lymphocytes, while the remaining 20% were either 
poorly stained, smudged or otherwise indistinguishable. An occasional mast 
cell (<1%) and a very occasional polymorphonuclear neutrophile (<<1%) 
were seen. 
3. Carbon Ingestion 
A physiologic differentiation of the two types of cells was therefore 
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attempted. Crude peritoneal exudate and purified preparations of 
"macrophages" and "lymphocytes" were prepared in Leighton tubes with cover- 
slips cut from the plastic bottoms of Falcon flasks. Each preparation was 
then incubated for one hour at 37°C. with carbon (Pelikan cH/1^31^ ^.Quted 
1:10,000. Microscopic examination showed that 63% of the crude exudate cells, 
97% of the "macrophage" preparation, and 7% of the "lymphocyte" preparation 
ingested carbon particles (>5/cell). It should be noted that these 
"purified" cell populations did not have the extra adsorption and washing 
steps used subsequently in preparing cells for experiments. 
A* Viability 
Cell viability was determined using the trypan blue exclusion 
technique. Cells were exposed to a 1:5 dilution of 0.4% trypan blue 
(Allied Chemical) for five minutes and examined microscopically. In 
preparations of crude peritoneal exudate, macrophages, and lymphocytes, an 
average of 99%, 93% and 96% of the cells, respectively, excluded the dye. 
H. INTERFERON PRODUCTION IN VITRO 
Cells to be tested for their ability to produce interferon were 
prepared in plastic flasks as described above. In virus experiments, 
duplicate cultures of cells from CV immune animals and BMB immune animals 
received 0.5 ml. CV (10 ^ dilution of the mouse brain preparation in 
maintenance medium). In most experiments CV immune cells, to which 0.5 ml. 
10% BMB had been added, served as a control. After preparations were 




In experiments with tuberculin sensitized cells, 25 yg./ml. PPD was 
added to the culture medium, the flasks were gassed, and then incubated for 
24 hours at 37°C. Control preparations are described in Results. 
1. INTERFERON ASSAY 
_1. Preparation of Samples 
Preparations to be assayed for interferon were clarified by 
centrifugation for 20 minutes at 10,000 r.p.m. (12, 350 g) in the refrigerated 
Sorvall. In the experiments where PPD was the interferon inducer, the 
clarified supernatant was assayed directly. 
When live virus was used as the interferon inducer, it had to be 
killed before the preparations could be assayed. This was achieved by 
aseptically pipetting the clarified preparation into 5/8 inch diameter 
dialysis tubing (Arthur H. Thomas Company) which had been knotted at one 
end and autoclaved in distilled water for 15 minutes. The other end of the 
tubing was then sealed with another knot and suspended by a string from the 
lip of an Erlenmeyer flask. The fluid in the tubing was dialyzed for 24 
hours at 4°C. against 20-30 volumes (as compared to the total volume of the 
preparations) of HC1, pH 2.0, and then neutralized by a six hour dialysis 
against ten volumes of Saline A. All preparations were stored at -40PC. 
A laboratory interferon standard was prepared from the brains of 
five week old male mice which had been intracerebrally infected with 0.1 ml. 
-4 West Nile virus diluted 10 . Three days after infection a 20% brain 
suspension in PBS was made from those animals and treated as above for 
virus-induced interferon preparations. The West Nile preparation maintained 
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a constant titer for more than six months when stored at -40°C. 
_2. The Assay 
Interferon activity was assayed by the plaque reduction method using 
L cells and Vesicular Stomatitis Virus. Interferon preparations were 
diluted by serial 2- or 4-fold dilutions in diluent (see Appendix) at 37°C. 
VSV was diluted with cold diluent so that 0.2 ml. of the final dilution 
£ 
would contain approximately 30-50 plaque forming units. 1.5x10 L cells in 
8-10 ml. of growth medium were pipetted into six cm. multiwell plastic 
plates (Linbro FB6-TC) and incubated at 37°C. in a humidified 5% CO^ 
atmosphere. In two to three days, when the cell sheet was a confluent 
monolayer, the growth medium was removed and two ml. of the interferon 
preparation was added and allowed to incubate at 37°C. for 3-20 hours. The 
incubation time in most experiments was six hours. The interferon 
preparations were then removed, the cell sheet was washed once with five ml. 
of warm PBS, and 0.2 ml. VSV was dropped onto the cells and incubated one 
hour at 37°C. The cell sheets were then overlaid with five ml. of the first 
agar overlay (see Appendix) and returned, inverted, to the incubator. The 
second agar overlay (see Appendix) was applied at 24-40 hours and the plaques 
were counted at 40-48 hours. 
_3. Variability 
The variability in the triplicate platings of the sample dilutions 
is somewhat greater than that usually acceptable in standard virus plaquing 
techniques. Similar variability is present, however, in the early interferon 
literature in which actual plaque counts were reported (19). In retrospect, 
the most likely source for the variability in the plaquing reported here is 
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in the method used to prepare the cell sheets. Aliquots of cells were 
pipetted in 0.5 ml. amounts into the dishes containing growth medium. A 
better method would have been to dilute the cells in the total volume of 
growth medium, thereby allowing larger volumes to be pipetted. In spite of 
the variability, _t tests reveal that the differences between some of the 





A. INTERFERON PRODUCTION BY CELLS FROM TUBERCULIN SENSITIZED ANIMALS 
Preliminary studies with peritoneal cells from ICR mice immunized 
with MT showed interferon production i_n vitro proportional to the amount of 
PPD added. Since PPD in concentrations greater than 50 yg./ml. is known to 
be cytotoxic, all further experiments used PPD at a concentration of 25 yg./ml. 
The results of two early experiments, although not statistically significant, 
suggested that the cells from immunized animals produced more interferon in 
the presence than in the absence of PPD, and that cells from control animals 
did not respond in that manner. 
Kantor has shown that different strains of mice vary greatly in their 
ability to exhibit tuberculin sensitivity, and that BALB/c mice are among 
the best responders (33). BALB/c mice were, therefore, used in the rest of 
the experiments to be described, and their delayed hypersensitivity to PPD 
was assessed by footpad testing. The results of such a test are shown in 
Table 1. 
Medium from the incubation of crude peritoneal exudate cells with and 
without PPD was assayed for interferon. The results, summarized in Table 2 
and Figures 1 and 2, show that cells from immune animals produced more 
interferon (as evidenced by plaque inhibition) in the presence of PPD than 
in its absence, whereas cells from control animals show no difference in 
interferon production. Table 2 also shows the results of a significance 
test done on these differences. Since it had been found that PPD affected 
the titration by increasing the number of plaques formed by a given amount 
of VSV, it was necessary to make the raw data comparable before calculating 
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the _t values. This was done by multiplying the number of plaques formed in 
PPD-containing samples by the factor which would make the expected number of 
VSV plaques formed in the presence of PPD equal to the number formed by VSV 
in the absence of PPD. 
As part of the last described experiment, purified macrophages and 
lymphocytes from the same group of animals were tested for their ability to 
produce interferon. It appeared that each type of cell produced some 
interferon, but that there was no difference in the responsiveness to PPD 
whether the cells came from sensitized animals or controls. This was also 
true for lymphocyte preparations cultured with or without PPD for 96 hours. 
Since each cell type alone did not appear capable of producing the 
response observed in the crude exudate preparations, the following 
experiment was done. Macrophages and lymphocytes, prepared in the usual 
manner, were recombined: sensitized lymphocytes with sensitized macrophages, 
sensitized lymphocytes with normal macrophages, normal lymphocytes with 
sensitized macrophages, and normal lymphocytes with normal macrophages. 
These were then incubated with or without PPD and the medium was assayed 
for interferon. The results, summarized in Table 3, suggest that, in the 
presence of PPD, sensitized lymphocytes with either tuberculin-sensitized 
or normal macrophages produce more interferon than these cells in the 
absence of PPD. The results of the footpad test done on litter mates of 
the animals used in the experiment are shown in Table 1. 
B. INTERFERON PRODUCTION BY CELLS FROM CV-IMMUNIZED ANIMALS 
The major portion of the experiments performed during the course of 
this study were done before the PPD experiments and were attempts to confirm 
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and extend the work reported by Glasgow with CV immune cells. In spite of 
the use of a variety of immunization routes, cell collection techniques, 
and cell culture conditions, none of the experiments resulted in evidence 
that cells from animals immunized with CV produced more interferon when 
exposed to CV in vitro than did cells from non-immune animals. Experimental 
protocols tried were: immunization by the intraperitoneal or intradermal 
routes with or without an oil adjuvant; collection of uninduced peritoneal 
exudates or exudates induced for 24 hours with trypticase soy broth; culture 
with either heat-inactivated fetal calf serum or heat-inactivated calf serum; 
and culture with or without antibiotics. Except where noted, the few 
experiments to be described followed the protocol as outlined in Materials 
and Methods. 
Early experiments (Table 4) showed that only very high multiplicities 
of virus induced interferon production in vitro, whether the cells came 
from animals immunized with CV or control animals which had received intra¬ 
peritoneal injections of baby mouse brain (BMB). 
A typical result from an experiment in which no antibiotics were 
used in the interferon preparations is seen in Table 5, which also shows the 
transformation of raw data into averages and percentages. The results fail 
to show any difference in plaque reduction caused by medium from CV cells 
exposed to CV when compared to medium from BMB cells exposed to CV. 
Of interest in these experiments was the observation that the purified 
preparations of macrophages and lymphocytes, obtained either from CV immune 
or control animals, and cultured in vitro with CV, produced a substance 
which depressed VSV plaque formation (Table 6). It should be noted that 
culture fluids from uninfected cells greatly increased the number of plaques 
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formed by a standard amount of VSV. Using the number of plaques formed by 
VSV on cells treated with these uninfected culture media as the expected or 
100% number of plaques, probit plots can be constructed which yield 50% 




The experimental work presented in this thesis provides evidence that 
peritoneal cells from animals with delayed hypersensitivity to PPD produce 
an enhanced interferon response when exposed to PPD i_n vitro, whereas cells 
from control animals do not. Cell separation and recombination experiments 
were done to ascertain the roles of macrophages and lymphocytes in producing 
this response. Similar experiments using Chikungunya virus as immunogen 
and interferon inducer failed to demonstrate any difference between cells 
from immune and control animals. 
Absent from the execution, but not the design, of these experiments 
was a demonstration that the viral interference which was repeatedly 
observed could be attributed to a substance whose biological and chemical 
properties allow it to be called an interferon. Therefore, interferon as 
used in discussing the work described here refers to the ability of certain 
culture media to inhibit VSV plaque formation on L cells when compared to 
an appropriate control. 
What were the appropriate controls? In the experiments reported by 
Glasgow, cells from immunized animals were compared with cells from non- 
immunized animals. Theoretically, at least, such a comparison is probably 
not valid. Immunization with a replicating antigen (BCG) has been shown to 
alter the relative proportions of the different cell types in guinea pig 
peritoneal exudate (AO). Nonspecific "activation" of macrophages in response 
to polyanions as described by Cohn (10) may also occur _in vivo, and then one 
must wonder how long such cells remain "activated," and if such nonspecific 




To allow for these possibilities, control cells for the virus 
experiments were from animals receiving injections of baby mouse brain. The 
primary aim of the virus experiments was to repeat Glasgow’s observation and, 
had this been done, a more ideal control would have been to immunize animals 
with two different viruses and show that the enhanced In vitro interferon 
response was specific for the immunizing virus. 
Control animals in the tuberculin experiments received injections of 
Bayol F; however, a different heat-killed bacterium like Brucella or Listeria 
would have been a better control. The theoretical objections were somewhat 
circumvented in these experiments by looking for differences in the same cells 
exposed to different stimuli, rather than for differences in different cells. 
One difficulty with the latter approach was that it became obvious 
that titration controls were crucial. The effect of PPD on VSV plaque 
formation had to be taken into account, as described above. In the absence 
of more complete evidence that the plaquing inhibitor observed was, in fact, 
interferon, the possibility exists that the inhibitor acted indirectly by 
preventing this plaquing enhancement caused by PPD. 
The results of the PPD experiments suggest that interferon is 
produced when tuberculin-sensitized cells are cultured in a manner similar 
to that used in demonstrations of in vitro manifestations of delayed 
hypersensitivity (MIF, CF, etc.). The report by Green et al, showing 
interferon production by lymphocytes from PPD-positive humans, cannot be 
compared with MIF or CF production since these authors cultured their cells 
for four to ten days (27). 
It was of interest to know whether a single cell type could produce 
the enhanced response or whether an interaction between lymphocytes and 
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macrophages was necessary. The recombination experiment showed that the 
sensitized lymphocyte is the key cell but says nothing about the necessity 
for macrophages. One experiment using purified cell populations suggested 
that sensitized lymphocytes alone cannot produce the observed response. 
Unfortunately, great variability in the titration controls for that 
particular experiment prevented meaningful comparisons, and no conclusion 
can be made from that experiment. Furthermore, the "purified" cell 
populations are still heterogeneous enough to make one hesitate to draw any 
conclusions about specific cells acting alone. For example, consider the 
small amounts of interferon produced in the virus experiments by the 
lymphocyte preparation (Figure 3). Does it come from low but detectable 
levels of production by the lymphocytes or from the 5% contaminating 
macrophages which are good interferon producers? This type of problem 
could be approached by mixing different proportions of "macrophages" and 
"lymphocytes." 
With regard to controls for the virus experiments, it was found that 
acidified calf serum increased the number of plaques formed by a standard 
amount of VSV. However, all culture media contained serum and this factor 
should not, therefore, have influenced comparison of preparations. On the 
other hand, the influence of acidified CV on VSV plaquing was not determined 
and, in retrospect, this would have been a desirable control. 
The failure of the virus experiments described here to confirm the 
work reported by Glasgow is rather typical of interferon work. Small 
differences in virus strain, cell clone, or animal species often greatly 
influence interferon production and assay. The animals and cells used in 
the present research may differ slightly from those used by Glasgow; 

29. 
neither work serologically confirmed the identity of the virus used. 
Glasgow, himself, has been unable to repeat his experiment using different 
viruses, but reports that a Japanese group successfully repeated the 
experiment using a virus with which he was unsuccessful (24). Subrahmanyan 
and Mims reported that they were unable to confirm Glasgow's experiment, 
but their experimental design was significantly different from his (48). 
Using an assay system in which the interferon-producing ability of individual 
spleen cells could be assayed, Osborn reported preliminary results which 
suggested that cells from immune animals were better producers of interferon 
when challenged with the homologous virus than were non-immune cells (41). 
Although the experimental results described in this thesis do not 
allow generalizations concerning delayed hypersensitivity, interferon 
production, and recovery from viral infections, they are suggestive enough 
to warrant a reevaluation of some heretofore puzzling experimental results. 
Stineberger and Rights found that vaccinia replicated far less well in 
freshly explanted spleen cells from vaccinated than from nonvaccinated 
rabbits (47). The difference was specific for vaccinia, was not observed 
with kidney cells, and could not be demonstrated if the spleen cells were 
first cultured for seven days. Flick and Pincus showed that rabbits 
tolerant to vaccinia develop generalized fatal vaccinia and do not produce 
the usual local vaccinia lesions (18). They suggested that delayed hyper¬ 
sensitivity was important in lesion formation and in protection against 
generalized vaccinia. Is it possible that localized delayed hypersensitivity 
reactions induce interferon production which is instrumental in localizing 
and inhibiting the virus? 
Turk et al sensitized guinea pigs with ultraviolet inactivated 
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vaccinia and challenged them with live vaccinia at a time (five days) when 
there was no circulating antibody to vaccinia (49). The skin test sites 
were then excised and titered for vaccinia. At 48, but not 24 hours after 
challenge, there was a ten fold greater amount of virus in non-immunized 
animals as compared to immunized animals. Animals sensitized with 
Mycobacterium tuberculosis and challenged with a mixture of PPD and vaccinia 
showed a "small but significant" decrease in vaccinia replication as 
compared to MT sensitized animals challenged with vaccinia but no PPD. 
Because the immunologically nonspecific or unrelated tuberculin reaction 
inhibited vaccinia multiplication nearly as well as the postulated specific 
reaction in vaccinated animals, the authors concluded that delayed hyper¬ 
sensitivity does not play an important part in the resolution of vaccinia 
infections. Had these authors known that delayed hypersensitivity reactions 
to PPD could result in interferon production, they might have interpreted 
their results as showing that delayed hypersensitivity to viruses inhibits 
virus multiplication and that this effect is mediated by increased interferon 




The Importance of interferon in the recovery from viral infections 
cannot be denied. Yet clinical observations, as well as some experimental 
data, suggest that the ability to develop delayed hypersensitivity reactions 
may also play a role in the normal recovery process. The mechanisms whereby 
interferon and delayed hypersensitivity reactions influence the outcome of 
viral infections may be entirely distinct, or they may be related. 
Experimental data reported in this thesis provide a link between the two and 
suggest a mechanism that would explain the role of delayed hypersensitivity. 
The data presented show that peritoneal cells from animals exhibiting 
delayed hypersensitivity to PPD produce more interferon when cultured 
in vitro with PPD than do cells from nonsensitized animals. This result 
appears to require the presence of both lymphocytes and macrophages. Cell 
separation and recombination experiments show that increased interferon 
production occurs only when the lymphocytes are obtained from sensitized 
animals, but that the macrophages may be obtained from either sensitized or 
nonsensitized animals. Attempts to show enhanced interferon production by 
cells from virus-sensitized animals exposed to the sensitizing virus were 
unsuccessful. Several experiments in the literature are reappraised in view 
of the possibility that interferon production as a manifestation of delayed 
























































EFFECT OF PPD ON INTERFERON PRODUCTION BY CRUDE PERITONEAL CELLS 
FROM TUBERCULIN SENSITIZED AND CONTROL ANIMALS 
Dilution of Culture Supernatant 



















52 ± 3.0, 
81 ± 9.41 
<0.01 
70 ± 5.7, 
95 ± 8.3* 
<0.02 
84 ± 2.5, 






77 ± 4.2, 
74 ± 7.81 
<0.8 
82 ± 2.3, 
89 ± 9.3* <0.3 
97 ± 4.5, 
105 ± 7.8* <0.5 
Cells from animals sensitized ten days before 24 hour _in vitro challenge. 
Plaques counted 48 hours after L cells had been treated with supernatants and 
infected with VSV. 
MT - Mycobacterium tuberculosis 
BF - Bayol F 
*From 9 plates for each dilution; triplicate determinations of three identical 
samples ± standard error of the mean. 
**From Student's jt test, where t = 
X!-x2 
2 2 




(Raw data for this calculation were corrected as discussed in Results.) 
VSV in presence of PPD produced 119 plaques. 
VSV in absence of PPD produced 110 plaques. 

Table 3 
INTERFERON PRODUCTION BY RECOMBINATIONS OF SENSITIZED AND NORMAL CELLS 
In Vivo 
Sensitizing 
- In Vitro 
Lymphs Macros Challenge 
1:5 











MT MT PPD 14 + 2'9} 
2.4; 
<0.3 
14 + !.! 
1.9 
<0.03 
17 + 1.7 
MT MT Diluent 18 + 19 + 28 + 2.4 
MT BF PPD 10 + 3.5 
1.3 
<0.001 
22 + 5.6, 
2.2"’ 
<0.3 
12 + 2.0 
MT BF Diluent 18 + 21 + 23 + 1.8 
BF MT PPD 17 + !.4 
2.1s <0.2 
17 + 2.4, 
2.1s <0.8 
18 + 2.0 
BF MT Diluent 13 + 21 + 21 + 1.1 
BF BF PPD 12 + 1.8 
2.8; 
<0.5 
12 + l.U 
2.6s <0.2 
20 + 2.7 





Abbreviations and calculations are the same as for Table 2. 
VSV in the presence of PPD produced 35 plaques. 
VSV in the absence of PPD produced 27 plaques. 

Table 4 







CV* 10'1 148 
CV io“2 170 
CV 10~3 224 
BMB** 10-1 153 
BMB io"2 151 
BMB io"3 199 
Cells = crude peritoneal cells from animals immunized with either CV or BMB. 
Vesicular stomatitis virus test dose = 198 ± 30 PFU. 
*Chikungunya Virus 
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Footnotes for Table 5 
*Crude peritoneal exudate cells from CV or BMB immunized animals incubated 
24 hours with CV (10~*). 
Plaques counted 40 hours after L cells had been treated with supernatants 
and infected with VSV. 
**Average plaques for combined samples of each cell type expressed ± standard 
error of the mean of the nine (or six) determinations at each dilution. 
Percentages are based on the number of plaques formed by the test dose of VSV 
on untreated L cells = 35 plaques. 

Table 6 
INTERFERON PRODUCTION BY MACROPHAGES AND LYMPHOCYTES 
Interferon Dilution 











Av g. No. 
of 
Plaques 
CV Macros CV 6 16 36 
CV Macros BMB 141 141 143 
BMB Macros CV 6 17 34 
CV Lymphs CV 72 95 109 
CV Lymphs BMB 110 108 148* 
BMB Lymphs CV 53 85 116 
Cells from animals hypersensitized eight weeks before 24 hour _in_ vitro 
challenge. 
Plaques counted 40 hours after L cells had been treated with supernatants 
and infected with VSV. 
Dose of VSV used in titration was 39 PFU. 
*This average was not statistically significantly different from the 
averages at the other two dilutions; therefore, in calculating the 
percentages used in plotting the data, the average of the three 




























PLAQUE INHIBITION BY MEDIA FROM THE INCUBATION 
OF MYCOBACTERIUM SENSITIZED CELLS WITH AND WITHOUT PPD 
(Dilution of Culture Supernatant) 
L cells pretreated for 24 hours with various media. 
VSV plaques counted 48 hours after cells infected. 
x medium from the 24 hour incubation of sensitized peritoneal cells 
with PPD. 
o medium from the 24 hour incubation of sensitized peritoneal cells 
without PPD. 
Points plotted ± one standard of the mean. 

Figure 2 
PLAQUE INHIBITION BY MEDIA FROM THE 
INCUBATION OF NORMAL CELLS WITH AND WITHOUT PPD 
L cells pretreated for 24 hours with various media. 
VSV plaques counted 48 hours after cells infected. 
x medium from the 24 hour incubation of normal peritoneal cells 
with PPD. 
o medium from the 24 hour incubation of normal peritoneal cells 
without PPD. 
Points plotted ± one standard error of the mean. 

Figure 3 
PLAQUE INHIBITION BY MEDIA FROM THE INCUBATION 
OF MACROPHAGES OR LYMPHOCYTES WITH CHIKUNGUNYA VIRUS 
(Dilution of Culture Supernatant)-^ 
L cells pretreated for five hours with various media. 
VSV plaques counted 48 hours after cells infected. 
. medium from the 24 hour incubation of CV sensitized macrophages with CV. 
o medium from the 24 hour incubation of BMB sensitized macrophages with CV. 
x medium from the 24 hour incubation of CV sensitized lymphocytes with CV. 





Medium 199 with Earles base (Grand Island Biological Co.) 
2% calf serum (Flow Laboratories) 
100 units/ml. potassium penicillin G (E.R. Squibb & Sons) 
100 yg./ml. streptomycin sulfate (Eli Lilly & Co.) 
B. CULTURE MEDIA 
_1. _L Cell Growth Medium 
Minimum Essential Medium (Eagle's) with Earles base (Grand Island 
Biological Co.) 
10% calf serum 
100 units/ml. potassium penicillin G 
100 yg./ml. streptomycin sulfate 
2_. Peritoneal Exudate Harvesting Medium 
Medium 199 with Earles base cnr Roswell Park Memorial Institute 
Medium 1640 (Microbiological Associates, Inc.) 
20% fetal calf serum heat inactivated for 30 min. at 56°C. (Grand 
Island Biological Co.) 
10 units/ml. sodium heparin (Organon, Inc.) 
100 units/ml. potassium penicillin G 
100 yg./ml. streptomycin sulfate 
3_. Peritoneal Exudate Maintenance Medium 
Roswell Park Memorial Institute Medium 1640 
20% fetal calf serum heat inactivated for 30 min. at 56°C. 
100 units/ml. potassium penicillin G 
100 yg./ml. streptomycin sulfate 

APPENDIX (Continued) 
4_. First Agar Overlay 
(a) Medium 199 with Earles base -2X 
4% calf serum 
200 units/ml. potassium penicillin G 
200 yg./ml. streptomycin sulfate 
Cb) 2 gm. Ionagar No. 2 (Oxoid) 
100 ml. distilled water 
Warm solution (a) to 37°C. in water bath. Cool freshly autoclaved 
solution (b) to 56°C. in water bath. Mix equal volumes of 
solutions (a) and (b) and use within 20 minutes. 
5_. Second Agar Overlay 
Prepare as first agar overlay except that solution (a) also 
contains 67 yg./ml. neutral red (National Aniline Division, 
Allied Chemical) 
Note: Minimum Essential Medium with Earles base. Medium 199 with Earles 
base, and Medium 199 with Earles base -2X were prepared from 
pre-mixed powders (Grand Island Biological Co.) 
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